| Literature DB >> 35032486 |
Yuanyuan Liu1, Nianyu Xue1, Boxi Zhang1, Hongming Lv2, Shize Li3.
Abstract
Thioredoxin-1 (Trx-1) is a small redox-active protein normally found in mammalian cells that responds to the changing redox environment by contributing electrons or regulating related proteins. There is growing evidence that Trx-1 has multiple functions, including cytoprotective, anti-apoptotic, antioxidant and anti-inflammatory effects. To date, researchers have found that Trx-1 deficiency leads to severe damage in various disease models, such as atherosclerosis, cerebral ischemia, diabetes and tumors. Conversely, activation of Trx-1 has a protective effect against these diseases. Accordingly, a variety of Trx-1 inducers have been widely used in the clinic with significant therapeutic value. In this paper, we summarize the pathogenesis of Trx-1 involvement in the above-mentioned diseases and describe the protective effects of Trx-1 inducers on them.Entities:
Keywords: Antioxidant; Cerebral ischemia; Inducers; Nitrosation; Thioredoxin-1 (Trx-1)
Mesh:
Substances:
Year: 2022 PMID: 35032486 DOI: 10.1016/j.ejphar.2022.174756
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432